Get the content you want anytime you want.
SHEA Spring 2018 Conference

Select coverage from SHEA Spring 2018 Conference is included below:

Are Prediction Risk Scores Matching up with Rapid Diagnostics?
Julie Ann Justo, PharmD, MS, BCPS-AQ ID, provides examples from her institution about using prediction scores and rapid diagnostic scores in concert.
Appropriate Treatment for Asymptomatic Bacteriuria
Barbara Wells Trautner, MD, PhD, explains the difference between asymptomatic bacteriuria and urinary tract infections.
Alternatives to Fluoroquinolones: Thinking Outside of the Box
Barbara Wells Trautner, MD, PhD, discusses finding alternatives to fluoroquinolones and facilitating patient communication to improve outcomes.
Why Are Health Care Providers Using Fluoroquinolones Despite the FDA Warning?
Barbara Wells Trautner, MD, PhD, discusses why physicians are using fluoroquinolones despite the FDA’s warning.
The Risk of Aortic Dissection and Aneurysm in Patients Taking Oral Fluoroquinolones
Barbara Wells Trautner, MD, PhD, explains the risk of aortic dissection and aneurysm in patients taking oral fluoroquinolones.  
New Research Touts Promise of Patient-Specific Antibiograms
New software unveiled last month suggests hospitals could make patient-specific predictions of antibiotic susceptibility.
Emotional Reaction Drives Some Clinicians to Prescribe Inappropriate Antibiotics
Julia E. Szymczak, PhD, shares the results of her study which revealed that fear drives some clinicians to prescribe inappropriately.
Fear Drives Inappropriate Prescribing of Antibiotics in Hospitals
This emotional drive carried throughout the continuum of the prescribing pathway, from initial prescription to stopping or de-escalating antibiotics.
Is there a cure? How long until we find it? And will it work for the majority of people living with HIV?